Close
Close
Treatment Database

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Product Indication Date Designated
Selegiline HCl As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism Nov 07, 1984
Spiramycin For symptomatic relief and parasitic cure of chronic cryptosporidiosis in patients with immunodeficiency Oct 17, 1984
Levocarnitine Primary and secondary carnitine deficiency of genetic origin Jul 26, 1984
viloxazine HCL Cataplexy and narcolepsy Jun 11, 1984
Clofazimine Lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum Jun 11, 1984
Pegademase bovine For enzyme replacement therapy for ADA deficiency in patients with severe combined immunodeficiency May 29, 1984
Ethanolamine oleate Patients with esophageal varices that have recently bled, to prevent rebleeding Mar 22, 1984
Hemin Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria Mar 16, 1984
Alpha-1-antitrypsin (recombinant DNA Origin) As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population Jan 01, 1984